Glycometabolic Control and Fibrinolysis in Diabetic Patients

J. W. J. van Wersch, L.W.J.J.M. Westerhuis, W.J.R.R. Venekamp

Haemostasis · 2009 · 15 citations · 0 references

Concepts

Abstract

We investigated 148 diabetic patients with regard to their relationship between fibrinolysis (D-dimer and plasminogen activator inhibitor; PAI) and glycometabolic control (HbA<sub>1c</sub>, HbA<sub>1</sub> and fructosamine). The percentage of moderately controlled patients as indicated by HbA<sub>1c</sub>, HbA<sub>1</sub> and fructosamine is relatively high (29.7, 41.7 and 30.4%, respectively). Simultaneously, the D-dimer and PAI levels turned out to be enhanced in 30.8 and 22.4% of the patients. There was a positive nonsignificant correlation between D-dimer and HbA<sub>1c</sub>, a highly significant negative correlation between D-dimer and HbA<sub>1</sub> and a nonsignificant negative correlation between D-dimer and fructosamine. According to the upper limits of the distinct reference ranges for HbA<sub>1c</sub>, HbA<sub>1</sub> and fructosamine, we splitted up the .D-dimer results and calculated the mean D-dimer values belonging to each category. Comparing the D-dimer means for each parameter, we separately obtained significant differences of the D-dimer means between the lower and higher HbA<sub>1</sub> and fructosamine groups, whereas in the case of HbA<sub>1c</sub> the mean D-dimer values of the categories under and over 9% showed no significant difference. For PAI, we found only weak nonsignificant positive correlations to D-dimer and fructosamine and weak but highly significant correlations to HbA<sub>1c</sub>. These results are indicative for an increase of PAI with diminished glycometabolic control as measured with the HbA<sub>1c</sub> and fructosamine level. Both D-dimer and PAI showed positive, highly significant correlations to the age of the diabetic patients, whereas HbA<sub>1c</sub> and fructosamine were age independent. The results described in this report demonstrate that the fibrin degradation to D-dimer fragments by the specific fibrinolytic enzyme plasmin is dependent on the glycometabolic control state as measured with HbA<sub>1</sub> and fructosamine and thus on the nonenzymatic glycosylation, which reduces the susceptibility of fibrin to degradation by plasmin.